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Methods of outcomes assessment need to be able
to gauge change in status after treatment in a mean-
ingful and objective way, and for purposes of analysis
and comparison, they should usually be quantitative
rather than qualitative. They should result in a prac-
tical assessment of the success of a given treatment
over time, whether applied to groups of patients of
varying levels of severity or patients grouped into
similar levels of severity. Both, but particularly the
former, require a quantitative method of gauging the
severity of disease. Properly comparing the outcomes
of two or more treatments in the same institution,
the reported results of the same treatment from dif-
ferent institutions, or the results of the same treat-
ment using different adjunctive measures is not pos-
sible unless the relative severities of the underlying
disease in the treatment groups are known.1
However, if the severity of the disease is uniformly
quantified and the score changes with treatment, a
disease severity score can not only serve as a back-
ground against which to view other outcome criteria
in comparing treatment groups, but can itself reflect
the degree of change in disease severity associated
with treatment. As such, disease severity scores can
be very useful in outcomes assessment. The wide-
spread use of a properly designed disease severity
scoring scheme should allow patient groups of simi-
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Some measure of disease severity is needed to properly compare the outcomes of the var-
ious approaches to the treatment of chronic venous insufficiency. Comparing the out-
comes of two or more different treatments in a clinical trial, or the same treatment in
two or more reports from the literature cannot be done with confidence unless the rel-
ative severity of the venous disease in each treatment group is known. The CEAP
(Clinical-Etiology-Anatomic-Pathophysiologic) system is an excellent classification
scheme, but it cannot serve the purpose of venous severity scoring because many of its
components are relatively static and others use detailed alphabetical designations. A dis-
ease severity scoring scheme needs to be quantifiable, with gradable elements that can
change in response to treatment. However, an American Venous Forum committee on
venous outcomes assessment has developed a venous severity scoring system based on the
best usable elements of the CEAP system. Two scores are proposed. The first is a Venous
Clinical Severity Score: nine clinical characteristics of chronic venous disease are graded
from 0 to 3 (absent, mild, moderate, severe) with specific criteria to avoid overlap or
arbitrary scoring. Zero to three points are added for differences in background conser-
vative therapy (compression and elevation) to produce a 30 point–maximum flat scale.
The second is a Venous Segmental Disease Score, which combines the Anatomic and
Pathophysiologic components of CEAP. Major venous segments are graded according to
presence of reflux and/or obstruction. It is entirely based on venous imaging, primari-
ly duplex scan but also phlebographic findings. This scoring scheme weights 11 venous
segments for their relative importance when involved with reflux and/or obstruction,
with a maximum score of 10. A third score is simply a modification of the existing CEAP
disability score that eliminates reference to work and an 8-hour working day, substitut-
ing instead the patient’s prior normal activities. These new scoring schemes are intend-
ed to complement the current CEAP system. (J Vasc Surg 2000;31:1307-12.) 
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lar degrees of severity to be selected for entry into
clinical trials and to be compared in regard to out-
come following different therapies. If generally
adopted, the reported outcomes after a given treat-
ment by different practices, groups, or institutions
can also be compared knowing the relative severity of
disease of the treated patients in each report. Thus a
venous severity scoring system can become a valuable
adjunct in venous outcomes assessment.
The increasingly popular CEAP (Clinical-
Etiology-Anatomic-Pathophysiologic2) classification
system, particularly its clinical classes C1 to C6, does
represent a progressive gradation of disease severity.
It gauges the severity of disease at a given point in
time, but because a number of its components are
relatively static and do not change significantly in
response to treatment and other components have
alphabetic designations, it cannot be used for disease
severity scoring in its current form. For example, the
healing of an active ulcer would drop the patient
from C6 to C5, but no further. Some of the ele-
ments of C4, particularly subcutaneous fibrosis and
cutaneous atrophy, are unlikely to change signifi-
cantly with treatment. The elimination of edema or
varicose veins, or reticular veins and telangiectasias
for that matter, conceivably could produce an
improvement in clinical class, but the results of their
treatment are not usually so absolute. Significant
improvements short of complete elimination of the
characteristic venous state would not result in cate-
gorical improvement. 
The clinical class of CEAP does not allow a prac-
tical assessment of change in response to treatment or
adverse events, but then it was not intended to do so.
Nevertheless, the American Venous Forum’s Ad Hoc
Committee on Venous Outcomes believed 
that CEAP identifies most if not all the necessary
components involved in comprehensive outcomes
assessment, and many of its elements could be indi-
vidually graded to produce a venous severity scoring
system. This approach was selected, and the results of
these deliberations are reported here. 
It should be noted that a “Clinical Score” is
included in the full CEAP document and is included
in the most recent edition of the Handbook of Venous
Disorders (see Table 38.3, page 656).2 It uses a 0 to
2 grading of a number of symptoms and signs, which
include pain and venous claudication, as well as the
characteristic elements of the C3 to C6 levels of
CEAP, for a maximum score of 18. Varicose veins are
not included in this clinical score, so a patient with
successful removal of these could only be gauged by
a change in pain, at the most two points. Although
the approach used in this clinical score is conceptual-
ly sound, it is rather simplistic. Furthermore, the
scores assigned can be rather arbitrary and subjective
because many of the scoring levels are inadequately
delineated by the descriptive terms associated with
them. Also, some of the characteristics (eg, number
of ulcers, duration of ulcers, recurrence of ulcers) are
not capable of improvement; the score can only
remain unchanged or increase. It has not gained
widespread acceptance or use and was not included
in the current version of venous reporting standards.3
In the development of a severity scoring system
based on CEAP, it was obvious that a clinical severi-
ty score could be primarily based on the C of CEAP,
and that the E or etiology is fixed and could not be
incorporated. However, both the anatomic (A) and
pathophysiology (P) segments, which essentially
involve the presence or absence of reflux and/or
obstruction, could be combined and adapted into a
grading scheme reflecting disease severity, and in
some situations even gauge change with treatment,
as in a comparison of anticoagulant therapy, throm-
bolysis, or thrombectomy for deep venous thrombo-
sis (DVT). It was believed that such a scheme could
be scored using duplex scan findings. Therefore, a
Venous Segmental Disease Score was also developed,
in addition to a Clinical Severity Score. These two
elements of the proposed venous severity scoring sys-
tem will thus be seen to be closely allied to CEAP. 
Finally, it was considered important to avoid con-
fusing or undermining the existing venous reporting
standards, and particularly the CEAP classification
system in developing new methods for venous out-
comes assessment such as venous severity scores. The
importance of the uniform classification framework
provided by CEAP is acknowledged and seen in its
increasing use. Thus, the goal of this report is not to
replace or change any aspect of the classification
scheme of CEAP, but to augment it with additional,
closely related, and compatible methods, some of
which are modifications of other features of CEAP
(ie, the clinical score and the disability score), to fur-
ther improve the ability to assess venous outcomes.
THE VENOUS CLINICAL SEVERITY
SCORE—A MODIFICATION TO REPLACE
THE CLINICAL SCORE OF CEAP
Design considerations and rationale. Although it
was considered desirable to use the basic clinical ele-
ments of CEAP where possible, it was important to not
mimic them so closely as to cause confusion with CEAP
classification. It was for this reason that simply scoring
each of the six clinical classes from 0 to 3 was rejected. 
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We wanted to take advantage of the progressive
order of severity intrinsic to the clinical classes of
CEAP, but also give additional weight to some of the
upper levels (C4 and C6). This was done by separate-
ly scoring certain attributes of each of these levels. 
It was necessary to avoid elements that are static
and use only those with ability to reflect change over
a relatively short period of time (months). Thus,
subcutaneous fibrosis, one of the hallmarks of C4,
was not considered. 
Because of its success in the Society for Vascular
Surgery and the International Society for Cardio-
vascular Surgery reporting standards4 and its com-
mon use by clinicians, we used the 0 to 3 grading
scheme and applied it to all clinical descriptors (0 =
absent, 1 = mild, 2 = moderate, and 3 = severe). This
allowed improvement at each level to be gauged. In
addition, it was important to define and describe
each level and each grade in sufficient detail to min-
imize overlap and arbitrariness in assigning scores. 
Both ascending and flat scales were considered
and, several were constructed. An ascending scale
assigns the score to the highest level achieved. Thus,
if six descriptors were each scored 0 to 3, the score
would increase from 0 to 18 for each box in ascend-
ing fashion. However, this approach did not fit with
our goal to develop a severity scoring scheme that
covered the full spectrum of disease with a wide
spread of scores capable of significant change with
treatment. One might achieve improvement in lower
descriptors (eg, remove varicosities, relieve edema,
and pain), but if there were little change in a higher
descriptor, the score would change little (eg, an ulcer
healed but pigmentation and induration remained).
In a flat scale, where points for each descriptor are
added to give the total score, this same degree of
improvement would result in a greater score change.
Therefore, a flat scale was chosen.
Clinical descriptors considered and chosen.
All six clinical class levels (C1-C6) as well as separate
characteristics of C4 to C6 (pigmentation, inflam-
mation, induration, ulcer size, number, multiplicity,
duration) were considered as potentially gradable
clinical descriptors. In addition, pain, disability, neu-
ropathy, venous eczema, and venous claudication
were considered.
C1 (telangiectasias and reticular veins) was elim-
inated because it was not considered a major patho-
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Table I. VCSS 
Attribute Absent = 0 Mild = 1 Moderate = 2 Severe = 3
Pain None Occasional, not restricting Daily, moderate activity Daily, severe limiting activities 
activity or requiring limitation, occasional or requiring regular use of 
analgesics analgesics analgesics
Varicose veins* None Few, scattered: branch VV’s Multiple: GS varicose veins Extensive: Thigh and calf or 
confined to calf or thigh GS and LS distribution
Venous edema† None Evening ankle edema only Afternoon edema, above ankle Morning edema above ankle 
and requiring activity 
change, elevation
Skin pigmentation‡ None or focal, Diffuse, but limited in area Diffuse over most of gaiter Wider distribution (above 
low intensity and old (brown) distribution (lower 1⁄3) or lower 1⁄3) and recent 
(tan) recent pigmentation (purple) pigmentation 
Inflammation None Mild cellulitis, limited to Moderate cellulitis, involves Severe cellulitis (lower 1⁄3 and 
marginal area around ulcer most of gaiter area (lower 1⁄3) above) or significant venous 
eczema
Induration None Focal, circummalleolar Medial or lateral, less than Entire lower third of leg or 
(< 5 cm) lower third of leg more
No. of active ulcers 0 1 2 > 2
Active ulceration, None < 3 mo > 3 mo, < 1 y Not healed > 1 y
duration 
Active ulcer, size§ None < 2-cm diameter 2- to 6-cm diameter > 6-cm diameter
Compressive Not used or Intermittent use of stockings Wears elastic stockings Full compliance: stockings + 
therapy|| not compliant most days elevation
*“Varicose” veins must be > 4-mm diameter to qualify so that diferentiation is ensured between C1 and C2 venous pathology. 
†Presumes venous origin by characteristics (eg, Brawny [not pitting or spongy] edema), with significant effect of standing/limb eleva-
tion and/or other clinical evidence of venous etiology (ie, varicose veins, history of DVT). Edema must be regular finding (eg, daily
occurrence). Occasional or mild edema does not qualify. 
‡Focal pigmentation over varicose veins does not qualify.
§Largest dimension/diameter of largest ulcer.
||Sliding scale to adjust for background differences in use of compressive therapy.
GS, Greater saphenous; LS, lesser saphenous.
logic characteristic of the patient with chronic
venous disease (CVD), the treatment of which was
the focus of these outcome assessment methods. C5
(healed ulcer) was also not represented because its
gradable characteristics (eg, total number of ulcers
or episodes of recurrent ulceration) were not capable
of positive change (ie, showing improvement). The
number of healed ulcers or episodes of ulceration
could only remain stable or increase. However,
improvement at this clinical level could be reflected
in improvements in pigmentation, induration, and
inflammation. 
Disability scoring was important in its own right
and was retained as a separate score. A new Venous
Disability Score (VDS) is presented separately below. 
Venous claudication was not included. It is much
rarer than other features of CVD, and besides,
patients with this degree of venous obstruction
would be represented with high scores for pain and
swelling. Neuropathy, while more common than
realized, was not considered common enough or
easily gauged by most investigators. Venous eczema
was considered for inclusion, not separately, but as a
severe form of inflammatory change. 
Ultimately, nine clinical descriptors were select-
ed: pain, varicose veins, edema, pigmentation,
induration, inflammation, number of active ulcers,
duration of active ulceration, and size of largest cur-
rent ulcer. There was considerable sentiment for
trying to compensate, in scoring, for background
differences in the use of compressive therapy and
limb elevation, because it was realized that, for
example, advanced skin changes without ulceration
in a very compliant patient may well represent more
severe disease than multiple active ulcers in a non-
compliant patient, or one who had never been
introduced to compressive therapy and elevation.
At one point, when a 30-point flat scale was being
worked on, a superimposed sliding scale of 0 to 3
was considered, with the score not to exceed 30.
When one of the descriptors was dropped in the
final deliberations, it was simply decided to include
0 to 3 points for differences in background conser-
vative therapy, bringing the severity score back to an
even 30-point scale. 
The venous clinical severity score (VCSS) finally
recommended is presented in Table I. It is accompa-
nied by qualifying comments regarding its application.
It is realized that the final version represents consider-
able arbitrariness and another group of “experts”
might have come up with a different scheme that
might also serve well. However, after months of delib-
eration, the committee could not arrive at a better
scheme, and it was believed that future field-testing, as
recommended below, would provide a more objective
basis for further modifying it.
THE VENOUS SEGMENTAL DISEASE
SCORE—A COMBINATION OF THE
ANATOMIC AND PATHOPHYSIOLOGIC
COMPONENTS OF CEAP
Design consideration and rationale. The con-
cept behind the Venous Segmental Disease Score
(VSDS) was to combine the pathophysiologic des-
ignation of reflux and obstruction with the venous
segments of the anatomic classification. Points are
assigned for pathophysiologic findings of reflux
and/or obstruction. At one point it was called the
Venous Anatomic-Pathophysiologic Score, but this
was considered awkward and not fully descriptive.
In addition to an objective score, one that could
complement the clinical score, a major motivation
for pursuing this approach was the opportunity to
gather the necessary information for scoring by
duplex scanning, which has become a standard in
investigating venous disease. 
However, 18 venous segments are designated for
the anatomic localization of disease in the CEAP clas-
sification system. We recognized that scoring all 18
would be unwieldy and unnecessarily complex, and
besides, not all could or would be evaluated by the
usual duplex scan. Furthermore, while some were
easy to eliminate as playing relatively insignificant
roles when incompetent or obstructed, the relative
roles of the remainder were not considered equal,
nor did they play as significant a role in obstruction
as reflux and vice versa. For example, superficial
venous incompetence is a common and significant
cause of venous insufficiency, but superficial vein
obstruction, by thrombus or ligation/excision,
played no significant role in obstruction of venous
return, except that the greater saphenous vein, if
thrombosed (or previously excised) could, as a major
collateral, contribute to the degree of obstruction in
femoropopliteal DVT. Allowance was made for this.
More proximal veins, such as the inferior vena
cava and the iliac and common femoral veins, play a
greater role in symptomatic venous obstruction than
many distal veins, but the first two play little role in
reflux because they normally have no valves.
Conversely, distal veins, specifically the popliteal and
tibial veins, play a greater role in producing venous
insufficiency than most proximal veins. Therefore,
after beginning by assigning one point to each of the
venous segments considered to play a significant role
in overall obstruction or reflux, we dropped those of
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lesser significance to one half and raised those of
greater significance to two. 
Finally, there was much discussion over whether
one should assign both obstruction and reflux
points to the same segment. Although it could be
said that any given abnormal segment would not be
refluxing if it were totally obstructed and it would
not be obstructed if patent and refluxing, in fact,
there are recanalized postthrombotic veins that are
incompetent, but also significantly narrowed.
Therefore, in concert with CEAP, those segments
with both reflux and significant obstruction
received points for both. This circumstance would
not be commonplace, but would not inappropriate-
ly give some cases of secondary, postthrombotic dis-
ease somewhat higher scores than those with pure
primary disease. However, the requirements for
assigning points for both are clearly spelled out to
avoid abuse. 
The final version of the VSDS is presented in
Table II, which includes qualifying comments
regarding its application. It is clear that this VSDS is
arbitrary, albeit after long deliberations. Therefore,
the committee recommends that further modifica-
tions be done after appropriate field-testing, using
objective correlative data. 
THE VENOUS DISABILITY SCORE—A
MODIFICATION OF THE ORIGINAL CEAP
DISABILITY SCORE
The disability score, originally developed with
CEAP, is featured in the Handbook of Venous
Disorders,2 but is not part of the revised venous
reporting standards.3 Unfortunately, in this version,
disability is related (score 2) to an 8-hour working
day and (score 3) the ability to work. It is believed
that this should be modified in recognition of the
many patients with CVD who do, or did, not ordi-
narily work an 8-hour day (eg, housewives, retirees,
students). That disability score also refers to the 
ability to work with or without “support device,”
which is not explained, but is presumed to mean
compression therapy. It was believed that support
device should be identified as compression therapy
with or without intermittent leg elevation, to avoid
misinterpretation by others, including those in
health care agencies. 
A slightly modified wording of the disability
score is therefore offered to accommodate the reali-
ty that not all individuals will be expected to work an
8-hour day while retaining the original concept of
compression therapy and intermittent limb elevation
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Table II. VSDS (based on venous segmental involvement with reflux or obstruction*) 
Reflux Obstruction†
1⁄2 Lesser saphenous ‡
1 Greater saphenous 1 Greater saphenous (only if thrombosed from groin to below knee)‡
1⁄2 Perforators, thigh ‡
1 Perforators, calf ‡
2 Calf veins, multiple (PT alone = 1) 1 Calf veins, multiple
2 Popliteal vein 2 Popliteal vein
1 Superficial femoral vein 1 Superficial femoral vein
1 Profunda femoris vein 1 Profunda femoris vein
1 Common femoral vein and above‡ 2 Common femoral
1 Iliac vein
1 IVC
10 Maximum reflux score§ 10 Maximum obstruction score§
Note: Reflux means that all the valves in that segment are incompetent. Obstruction means there is total occlusion at some point in the
segment or > 50% narrowing of at least half of the segment. Most segments are assigned one point, but some segments have been weight-
ed more or less to fit with their perceived significance (eg, increasing points for common femoral or popliteal obstruction and for
popliteal and multiple calf vein reflux and decreasing points for lesser saphenous or thigh perforator reflux). Points can be assigned for
both obstruction and reflux in the same segment. This will be uncommon but can occur in some postthrombotic states, potentially giv-
ing secondary venous insufficiency higher severity scores than primary disease. 
*As determined by appropriate venous imaging (phlebography or duplex scan). Although some segments may not be routinely studied
in some laboratories (eg, profunda femoris and tibial veins), points cannot be awarded on the basis of presumption, without interrogat-
ing the segments for obstruction or reflux.
†The excision, ligation, or traumatic obstruction of deep venous segments counts toward obstruction points just as much as their throm-
bosis.
‡Normally there are no valves above the common femoral vein, so no reflux points are assigned to them. In addition, perforator inter-
ruption and saphenous ligation/excision do not count in the obstruction score, but as a reduction of the reflux score.
§Not all of the 11 segments can be involved in reflux or obstruction. Ten is the maximum score that can be assigned, and this might be
achieved by complete reflux at all segmental levels.
IVC, Inferior vena cava; PT, posterior tibial.
facilitating maintenance of reasonable or usual daily
activities. “Usual activities” is further qualified as
being normal for the patient (ie, those carried on
before being disabled by venous disease). This mod-
ification, presented in Table III, is intended to
widen the application of this aspect of CEAP to a
broader population.
CONCLUSIONS
The need and potential value of disease severity
scoring in venous outcomes assessment seems clear
to the committee. The added perspective of com-
bining a VCSS with a segmental disease score based
on objective imaging data (the VSDS) is also
attractive. It is recommended that both scores be
used wherever possible, rather than one or the
other, and the VDS should be included for addi-
tional perspective. Only their use in clinical studies
will determine the degree to which they correlate
with each other and/or change in parallel in
response to treatment. However, these scores rep-
resent the view of a few individuals and, as such,
are admittedly arbitrary. It is clear that such a sever-
ity scoring system would best be based on data
from large multicenter studies of patients with
venous disease, in whom clinical and duplex scan
data were gathered and correlated with CEAP clas-
sification, other outcome criteria, and tests of
venous function. Such studies are still needed in
order to evaluate and modify it.
However, in spite of many years of physiologic
testing, there is little agreement on universally
accepted tests for reflux and obstruction, and
although 6 years of venous evaluation using CEAP
have brought us closer, we simply do not yet have
the data from its use at this point in time to develop
a venous scoring system more objectively. We enthu-
siastically advocate and encourage such correlative
studies and sincerely hope they will be forthcoming,
but this prospective approach will require consider-
able time, even if it began immediately. In the mean-
time, these venous severity scores are offered now to
provide additional needed dimensions to compar-
isons of venous outcomes. 
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Table III. VDS
0 = asymptomatic
1 = symptomatic but able to carry out usual activities* with-
out compressive therapy
2 = can carry out usual activities* only with compression and/
or limb elevation
3 = unable to carry out usual activities* even with compression
and/or limb elevation
*Usual activities = patients activities before onset of disability from
venous disease.
